Home

ReShape Lifesciences, Inc. - Common Stock (RSLS)

0.3832
+0.0735 (23.73%)
NASDAQ · Last Trade: Apr 21st, 5:17 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.3097
Open0.4613
Bid0.3930
Ask0.3940
Day's Range0.3723 - 0.4925
52 Week Range0.3000 - 29.00
Volume150,626,895
Market Cap2.36M
PE Ratio (TTM)-0.1201
EPS (TTM)-3.2
Dividend & YieldN/A (N/A)
1 Month Average Volume36,461,200

Chart

About ReShape Lifesciences, Inc. - Common Stock (RSLS)

Reshape Lifesciences Inc is a biotechnology company focused on developing innovative medical technologies and solutions for weight management and obesity-related health issues. The company's primary aim is to enhance patient outcomes through its proprietary products, which include minimally invasive procedures designed to aid in weight loss and promote healthier lifestyles. By leveraging advanced engineering and clinical expertise, Reshape Lifesciences seeks to address the growing global health crisis associated with obesity and its complications, ultimately striving to empower individuals to take control of their health through effective interventions. Read More

News & Press Releases

Here are the top movers in Monday's session.chartmill.com
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · April 21, 2025
Most active stocks in Monday's sessionchartmill.com
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via Chartmill · April 21, 2025
Top movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session.chartmill.com
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · April 21, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · April 21, 2025
The market is filled with gapping stocks in Monday's session.chartmill.com
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · April 21, 2025
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia
By ReShape Lifesciences Inc · Via GlobeNewswire · April 21, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · April 14, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · April 11, 2025
Top stock movements in today's session.chartmill.com
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · April 10, 2025
Most active stocks in Thursday's sessionchartmill.com
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session.
Via Chartmill · April 10, 2025
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.chartmill.com
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · April 10, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · April 10, 2025
These stocks are gapping in today's sessionchartmill.com
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · April 10, 2025
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jumpmarkets/com
Via Benzinga · April 10, 2025
Which stocks are moving before the opening bell on Thursday?chartmill.com
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · April 10, 2025
Dow Tumbles Over 800 Points; US Inflation Rate Falls In Marchbenzinga.com
Via Benzinga · April 10, 2025
Penny Stock ReShape To Distribute FDA-Cleared Neuromuscular Device In USbenzinga.com
ReShape Lifesciences will distribute Motion Informatics' FDA-cleared Stimel-03 rehab device in the U.S., targeting stroke and injury recovery markets.
Via Benzinga · April 10, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 10, 2025
US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights 'Fairly Weak Returns' After 5%+ Gains In S&P 500benzinga.com
Via Benzinga · April 10, 2025
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · April 10, 2025
Curious about the stocks that are showing activity after the closing bell on Wednesday?chartmill.com
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · April 9, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · April 9, 2025
ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
ReShape Enters Exclusive U.S. Distribution Agreement in the Neuromuscular Rehabilitation Market
By ReShape Lifesciences Inc · Via GlobeNewswire · April 9, 2025
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
Significant Reduction in Overall Operating Expenses of 41.9% in 2024, Excluding M&A Related Expenses, Compared to 2023
By ReShape Lifesciences Inc · Via GlobeNewswire · April 7, 2025
Unusual volume stocks are being observed in Monday's session.chartmill.com
These stocks have an unusual volume in today's session
Via Chartmill · April 7, 2025